InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+31.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Powell Lynne, Director. Director active across 3 companies, notably PROGENITY, INC.. Cumulatively, 7 reports have been published. Activity tracked since 14 June 2021. The latest transaction was filed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
12,500 shares0Common StockSEC:0000950170-24-069929:0
12,500 shares0Common StockSEC:0000950170-23-028596:0
45 sharesSeries X Preferred StockSEC:0000899243-23-000960:0
96,154 shares0Common StockSEC:0000899243-22-023090:0
29,183 shares0Common StockSEC:0000899243-21-024210:0
29,183 shares0Common StockSEC:0000899243-21-024210
3,850 sharesCommon StockSEC:0001127602-16-038015:0
7 of 7 declarations
About Powell Lynne
Lynne Powell is a Board Member at PROGENITY, INC. and BIORA THERAPEUTICS, INC. She contributes to the governance of the companies, bringing her expertise in the biotechnology sector. Her role on the boards is essential for strategic development.
